Capricor Therapeutics logo
Capricor Therapeutics CAPR
$ 18.61 0.11%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Capricor Therapeutics Balance Sheet 2011-2024 | CAPR

Annual Balance Sheet Capricor Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-12.5 M -7.04 M -32 M -32.3 M -523 K -883 K -6.14 M 23.7 M 11.6 M 1.12 M 2.56 M -46.7 K -1.04 M

Long Term Debt

1.49 M 1.88 M 2.45 M 71.5 K - - - 13.9 M 9.16 M 9.16 M 3.96 M - -

Long Term Debt Current

749 K 682 K 418 K - - - - - - - - - -

Total Non Current Liabilities

4.86 M 14.7 M 5.83 M 3.45 M 3.38 M 3.38 M 3.38 M 17.9 M 10.6 M 13.6 M 4.02 M 63.4 K -

Total Current Liabilities

31.3 M 23.6 M 4.13 M 2.97 M 898 K 1.26 M 1.67 M 4.9 M 6.53 M 6.3 M 2.05 M 331 K 541 K

Total Liabilities

36.1 M 38.3 M 9.96 M 6.42 M 4.27 M 4.63 M 5.05 M 22.8 M 17.1 M 19.9 M 6.07 M 394 K 541 K

Deferred Revenue

24.3 M 18 M - - - - - 1.37 M 3.65 M 4.17 M - - -

Retained Earnings

-159 M -137 M -108 M -88 M -74.4 M -66.7 M -51.5 M -54 M -35.2 M -22.3 M -16.1 M -46.7 M -44.8 M

Total Assets

58.7 M 50.1 M 41.3 M 34.6 M 11.1 M 9.25 M 16.3 M 18.7 M 16.1 M 13.6 M 5.54 M 227 K 1.37 M

Cash and Cash Equivalents

14.7 M 9.6 M 34.9 M 32.7 M 3.9 M 4.26 M 6.14 M 3.2 M 5.57 M 8.03 M 1.73 M 170 K 1.04 M

Book Value

22.6 M 11.8 M 31.4 M 28.2 M 6.84 M 4.62 M 11.2 M -4 M -1.03 M -6.25 M -535 K -167 K 831 K

Total Shareholders Equity

22.6 M 11.8 M 31.4 M 28.2 M 6.84 M 4.62 M 11.2 M -4 M -1.03 M -6.25 M -535 K 4.89 M 1.66 M

All numbers in USD currency

Quarterly Balance Sheet Capricor Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.04 M 1.25 M 1.49 M 1.68 M 1.52 M 1.7 M 1.88 M 2.08 M 2.16 M 2.31 M 2.45 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

4.42 M 4.63 M 4.86 M 6.01 M 8.13 M 10.5 M 14.7 M 15.3 M 19.8 M 26 M 5.83 M 3.38 M 3.38 M 3.41 M 3.45 M 3.45 M 3.45 M 3.45 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 3.38 M 17.9 M 17.9 M 17.9 M 17.9 M 10.6 M 10.6 M 10.6 M 10.6 M 13.6 M 13.6 M 13.6 M 13.6 M 4.02 M 4.02 M 4.02 M - - - - - - - - -

Total Liabilities

26.8 M 31 M 36.1 M 38.9 M 43.3 M 47.7 M 38.3 M 38.5 M 39.3 M 40.3 M 9.96 M 6.36 M 6.55 M 7.16 M 6.42 M 6.42 M 6.42 M 6.42 M 4.27 M 4.27 M 4.27 M 4.27 M 4.63 M 4.63 M 4.63 M 4.63 M 5.05 M 5.05 M 5.05 M 5.05 M 22.8 M 22.8 M 22.8 M 22.8 M 17.1 M 17.1 M 17.1 M 17.1 M 19.9 M 19.9 M 19.9 M 19.9 M 6.07 M 6.07 M 6.07 M 6.07 M 529 K 394 K 394 K 394 K 541 K 541 K 541 K -

Deferred Revenue

15.4 M 19.4 M 24.3 M 25.4 M 29.3 M 31 M 18 M 18.6 M 15.7 M 9.73 M - - - - - - - - - - - - - - - - - - - 684 K 1.37 M 1.37 M 1.37 M 1.37 M 3.65 M 3.65 M 3.65 M 3.65 M 4.17 M 4.17 M 4.17 M 4.17 M - - - - - - - - - - - -

Retained Earnings

-180 M -169 M -159 M -159 M -152 M -145 M -137 M -129 M -123 M -116 M -108 M -102 M -97.9 M -93.2 M -88 M -88 M -88 M -88 M -74.4 M -74.4 M -74.4 M -74.4 M -66.7 M -66.7 M -66.7 M -66.7 M -51.5 M -51.5 M -51.5 M -51.5 M -54 M -54 M -54 M -54 M -35.2 M -35.2 M -35.2 M -35.2 M -22.3 M -22.3 M -22.3 M -22.3 M -16.1 M -48.1 M -47.8 M -47.2 M -46.7 M -46.5 M -46.7 M -46.7 M -44.8 M -44.8 M -44.8 M -44.8 M

Total Assets

38.3 M 49.4 M 58.7 M 37.2 M 46 M 53.9 M 50.1 M 53.9 M 58.1 M 64.9 M 41.3 M 43.1 M 39.9 M 43.5 M 34.6 M 34.6 M 34.6 M 34.6 M 11.1 M 11.1 M 11.1 M 11.1 M 9.25 M 9.25 M 9.25 M 9.25 M 16.3 M 16.3 M 16.3 M 16.3 M 18.7 M 18.7 M 18.7 M 18.7 M 16.1 M 16.1 M 16.1 M 16.1 M 13.6 M 13.6 M 13.6 M 13.6 M 5.54 M 5.54 M 5.54 M 5.54 M 5.42 M 227 K 227 K 227 K 1.37 M 1.37 M 1.37 M 1.37 M

Cash and Cash Equivalents

10.7 M 6.21 M 14.7 M 8.98 M 9.84 M 10.6 M 9.6 M 8.41 M 16.4 M 58.3 M 34.9 M 40.8 M 38.1 M 41.9 M 32.7 M 32.7 M 32.7 M 32.7 M 3.9 M 3.9 M 3.9 M 3.9 M 4.26 M 4.26 M 4.26 M 4.26 M 6.14 M 6.14 M 6.14 M 6.14 M 3.2 M 3.2 M 3.2 M 3.2 M 5.57 M 5.57 M 5.57 M 5.57 M 8.03 M 8.03 M 8.03 M 8.03 M 1.73 M 1.73 M 1.73 M 1.73 M 170 K 46.7 K 46.7 K 46.7 K 1.55 M 1.04 M 1.04 M 1.04 M

Book Value

11.5 M 18.4 M 22.6 M -1.79 M 2.73 M 6.21 M 11.8 M 15.4 M 18.7 M 24.6 M 31.4 M 36.7 M 33.4 M 36.4 M 28.2 M 28.2 M 28.2 M 28.2 M 6.84 M 6.84 M 6.84 M 6.84 M 4.62 M 4.62 M 4.62 M 4.62 M 11.2 M 11.2 M 11.2 M 11.2 M -4 M -4 M -4 M -4 M -1.03 M -1.03 M -1.03 M -1.03 M -6.25 M -6.25 M -6.25 M -6.25 M -535 K -535 K -535 K -535 K 4.89 M -167 K -167 K -167 K 831 K 831 K 831 K 1.37 M

Total Shareholders Equity

11.5 M 18.4 M 22.6 M -1.79 M 2.73 M 6.21 M 11.8 M 15.4 M 18.7 M 24.6 M 31.4 M 36.7 M 33.4 M 36.4 M 28.2 M 28.2 M 28.2 M 28.2 M 6.84 M 6.84 M 6.84 M 6.84 M 4.62 M 4.62 M 4.62 M 4.62 M 11.2 M 11.2 M 11.2 M 11.2 M -4 M -4 M -4 M -4 M -1.03 M -1.03 M -1.03 M -1.03 M -6.25 M -6.25 M -6.25 M -6.25 M -535 K -535 K -535 K -535 K 4.89 M -167 K -167 K -167 K 1.66 M 831 K 831 K 831 K

All numbers in USD currency